(Q46570622)

23 December 2017

title

Single-dose pharmacokinetics of roflumilast in children and adolescents (English)

1 reference

23 December 2017

1 reference

1 reference

2

Stanley J Szefler

1 reference

23 December 2017

9

Gregory L Kearns

1 reference

23 December 2017

author name string

Kathleen A Neville

1

1 reference

23 December 2017

Susan M Abdel-Rahman

3

1 reference

23 December 2017

Gezim Lahu

4

1 reference

23 December 2017

Karl Zech

5

1 reference

23 December 2017

Rolf Herzog

6

1 reference

23 December 2017

Thomas D Bethke

7

1 reference

23 December 2017

Melanie C Gleason

8

1 reference

23 December 2017

publication date

28 May 2008

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

48

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

978-985

1 reference

23 December 2017

Prevalence and etiology of asthma

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Environmental epidemiology of pediatric asthma and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Phosphodiesterase inhibitors in airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

Developmental pharmacology--drug disposition, action, and therapy in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319466

21 January 2018

Identifiers

DOI

10.1177/0091270008319466

1 reference

23 December 2017

1 reference

23 December 2017